Molecular Studies of Retinal Degeneration in Drosophila

描述（由申请人提供）：我们的长期目标是解开遗传性人类致盲疾病的分子遗传学，如视网膜色素变性（RP）和年龄相关性黄斑变性（AMD）。导致AMD和RP感光细胞死亡的遗传缺陷具有高度异质性，现在包括超过132个基因的列表。AMD和RP中复杂和多样的临床和遗传学发现表明存在多种疾病亚型，每种亚型具有不同的遗传和生化基础。这种复杂性、RP和AMD患者眼组织的罕见可用性以及果蝇遗传学知识的广泛基础，所有这些联合收割机结合起来使果蝇成为研究遗传性视网膜变性疾病的强大动物模型。我们建议使用果蝇作为一个模型，以确定和表征人类致盲疾病的新位点，提供视网膜变性的分子基础的机制见解。我们将使用遗传学，生物化学，细胞生物学，电生理学和分子方法的综合策略来揭示感光细胞中协调蛋白质生物合成的多种分子信号传导机制。我们的研究重点是确保正确折叠，修饰，寡聚体组装，质量控制，运输和靶向新合成蛋白质的事件。这些过程中的缺陷往往会刺激广泛的细胞反应，导致发病机制，在严重的情况下，神经变性。在这里，我们将描述分子伴侣钙连接蛋白，和4个新的位点，在钙连接蛋白途径的功能：cip 1，cip 2，cip 3和cip 4。钙连接蛋白是一种分子伴侣，促进内质网（ER）中新生糖蛋白的正确折叠。在离开内质网后，新折叠的蛋白质必须被转运到高尔基体，在那里它们经历一系列新的修饰。蛋白质在两个隔室之间的运输通过囊泡的出芽和融合发生。我们将描述一种新的感光陷阱蛋白所需的囊泡融合事件在高尔基体。我们已经证明，钙连接蛋白，cip 1 -4和圈套基因的突变导致视紫红质表达的缺陷，并导致视网膜变性。我们的研究结果将用于筛选人类AMD和RP家系的类似突变。我们的目标是发现致盲疾病的新位点，提供视网膜变性的分子机制的见解，并提供治疗RP和AMD的治疗方法。

DESCRIPTION (provided by applicant): Our long-term objective is to unravel the molecular genetics of hereditary human blinding diseases, such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Genetic defects that lead to photoreceptor cell death in AMD and RP are highly heterogeneous and now include a list of more than 132 genes. The complex and various clinical and genetic findings in AMD and RP suggest that there are multiple subtypes of the diseases, each with a distinct genetic and biochemical basis. This complexity, the infrequent availability of ocular tissues from RP and AMD patients, and the broad base of knowledge of Drosophila genetics, all combine to make Drosophila a powerful animal model for studying inherited retinal degeneration disorders. We propose to use Drosophila as a model to identify and characterize novel loci in human blinding diseases, providing mechanistic insights into the molecular basis of retinal degeneration. We will use an integrated strategy of genetic, biochemical, cell biological, electrophysiological, and molecular approaches to uncover the diverse molecular signaling mechanisms that coordinate protein biosynthesis in photoreceptor cells. Our research focuses on those events that ensure correct folding, modification, oligomeric assembly, quality control, trafficking and targeting of newly synthesized proteins. Defects in these processes often stimulate extensive cellular responses that lead to pathogenesis and, in severe cases, neurodegeneration. Here, we will characterize the molecular chaperone calnexin, and 4 novel loci that function in the calnexin pathway: cip1, cip2, cip3 and cip4. Calnexin is a molecular chaperone that promotes the proper folding of nascent glycoproteins in the endoplasmic reticulum (ER). Upon exiting the ER, newly folded proteins must be transported to the Golgi where they undergo a new set of modifications. Transport of proteins between the two compartments occurs via the budding and fusion of vesicles. We will characterize a novel photoreceptor SNARE protein required for vesicular fusion events in the Golgi. We have shown that mutations in calnexin, cip1-4 and the snare gene cause defects in rhodopsin expression and lead to retinal degeneration. Our findings will be used to screen human AMD and RP pedigrees for similar mutations. We aim to uncover novel loci in blinding diseases, provide insights into the molecular mechanisms of retinal degeneration, and offer therapeutic approaches for treating RP and AMD.